{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:17:37Z","timestamp":1779196657553,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Herbal medicine-induced hepatotoxicity is a significant contributing factor to drug-induced liver injury (DILI), but the mechanisms underlying herbal medicine-induced hepatotoxicity remain unclear. This study reports a well-documented probable case of DILI caused by Huzhang (Polygoni Cuspidati Rhizoma et Radix) to elucidate its clinical presentation and potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 72-year-old patient developed hepatocyte-type damage after continuous administration of a Huzhang-containing formula for 14 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>After ruling out other causes via comprehensive exams, we reviewed the literature, excluded other medications, and applied the updated Roussel Uclaf Causality Assessment Method, which gave a score of 6 for Huzhang-induced DILI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with N-acetylcysteine and other supportive medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient\u2019s liver function returned to normal after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The hepatotoxicity mechanism of emodin in Huzhang was explored, and it was suggested that traditional Chinese medicines containing emodin, such as Huzhang, should be cautious about hepatotoxicity risks, particularly in elderly patients, long-term users, and those with a history of surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047385","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:01:49Z","timestamp":1769965309000},"page":"e47385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A case report and a literature review of drug-induced liver injury caused by Huzhang according to the updated RUCAM"],"prefix":"10.1097","volume":"105","author":[{"given":"Xinyan","family":"Liang","sequence":"first","affiliation":[{"name":"Drug Clinical Trial Institution, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Department of Clinical Pharmacy, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjiong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-8263","authenticated-orcid":false,"given":"Wenliang","family":"Dun","sequence":"additional","affiliation":[{"name":"Drug Clinical Trial Institution, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Department of Clinical Pharmacy, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00018-025-05744-3","article-title":"Mechanisms of drug-induced liver injury.","volume":"82","author":"Skat-R\u00f8rdam","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"R2-20260519","first-page":"355","article-title":"Chinese guidelines for the diagnosis and treatment of drug-induced liver injury (2023 Edition).","volume":"31","year":"2023","journal-title":"Chin J Hepatol"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in Mainland China.","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"R4-20260519","first-page":"813","article-title":"Guidelines for primary care diagnosis, treatment, and management of drug-induced liver injury in China (2024).","volume":"23","year":"2024","journal-title":"Chin J Gen Pract"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14218\/JCTH.2017.00033","article-title":"Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury.","volume":"6","author":"Jing","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"R7-20260519","first-page":"5917","article-title":"Research progress on terpenoid components and pharmacological effects of wood fragrance.","volume":"45","author":"Yang","year":"2020","journal-title":"Chin J Trad Chin Med"},{"key":"R8-20260519","first-page":"6020","article-title":"Study on the protective effect of wood fragrance ethanol extract on lipopolysaccharide-induced liver injury in rats.","volume":"38","author":"Shen","year":"2023","journal-title":"Chin J Trad Medi"},{"key":"R9-20260519","first-page":"4556","article-title":"Chemical constituents of Sichuan wood fragrant and its anti-lipopolysaccharide-induced liver injury effects.","volume":"56","author":"Lei","year":"2025","journal-title":"Chinese Herbal Medicines"},{"key":"R11-20260519","first-page":"9","article-title":"Determination of rhein content in different processed forms of rhubarb by HPLC.","volume":"40","author":"Jianhua","year":"2006","journal-title":"Chin J Vet Drugs"},{"issue":"Pt B","key":"R12-20260519","doi-asserted-by":"crossref","first-page":"117010","DOI":"10.1016\/j.jep.2023.117010","article-title":"Comparative pharmacokinetics and tissue distribution of polydatin, resveratrol, and emodin after oral administration of Huzhang and Huzhang-Guizhi herb-pair extracts to rats.","volume":"318","author":"Yang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jep.2012.10.009","article-title":"Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats.","volume":"144","author":"Lin","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"R14-20260519","first-page":"425","article-title":"The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin.","volume":"18","author":"Cui","year":"2020","journal-title":"Chin J Nat Med"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"e33631","DOI":"10.1016\/j.heliyon.2024.e33631","article-title":"Advances in the mechanism of emodin-induced hepatotoxicity.","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cells8030263","article-title":"Inhibition of mitochondrial complex function-the hepatotoxicity mechanism of emodin based on quantitative proteomic analyses.","volume":"8","author":"Lin","year":"2019","journal-title":"Cells"},{"key":"R17-20260519","first-page":"3079","article-title":"Mechanistic study on long-term rhein-induced liver injury and bile acid metabolism.","volume":"50","author":"Jingzhuo","year":"2025","journal-title":"Chin J Trad Chin Med"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.16156","article-title":"Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation of glutaminase 1.","volume":"180","author":"Chen","year":"2023","journal-title":"Br J Pharmacol"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury.","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population-based case-control study.","volume":"58","author":"de Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2468-1253(20)30006-6","article-title":"Drug-induced liver injury in older people.","volume":"5","author":"Lucena","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1111\/bcp.14847","article-title":"Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: a matched case-control study.","volume":"87","author":"Kong","year":"2021","journal-title":"Br J Clin Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:03:15Z","timestamp":1779195795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047385","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}